Pulmonx (LUNG) Non-Current Deferred Tax Liability (2019 - 2025)
Pulmonx (LUNG) has disclosed Non-Current Deferred Tax Liability for 7 consecutive years, with $47000.0 as the latest value for Q3 2025.
- Quarterly Non-Current Deferred Tax Liability fell 63.57% to $47000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $47000.0 through Sep 2025, down 63.57% year-over-year, with the annual reading at $87000.0 for FY2024, 23.68% down from the prior year.
- Non-Current Deferred Tax Liability for Q3 2025 was $47000.0 at Pulmonx, up from $41000.0 in the prior quarter.
- The five-year high for Non-Current Deferred Tax Liability was $140000.0 in Q1 2024, with the low at $37000.0 in Q4 2021.
- Average Non-Current Deferred Tax Liability over 5 years is $79526.3, with a median of $71000.0 recorded in 2021.
- The sharpest move saw Non-Current Deferred Tax Liability skyrocketed 154.05% in 2022, then tumbled 65.25% in 2025.
- Over 5 years, Non-Current Deferred Tax Liability stood at $37000.0 in 2021, then soared by 154.05% to $94000.0 in 2022, then increased by 21.28% to $114000.0 in 2023, then decreased by 23.68% to $87000.0 in 2024, then crashed by 45.98% to $47000.0 in 2025.
- According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods came in at $47000.0, $41000.0, and $79000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.